The treatment of benign prostatic hyperplasia

a prospective, randomized clinical trial to be conducted by the American Urological Association

H. Logan Holtgrewe

Research output: Contribution to journalArticle

Abstract

Through a large nationwide, multicenter, prospective, randomized and preferential clinical trial, the American Urological Association plans to evaluate the efficacy of watchful waiting, alpha-blockade, balloon dilation, and transurethral prostatectomy (TURP) in the treatment of benign prostatic hyperplasia. The study, to be conducted at 20 major urological centers in the United States, will primarily address the issue of long-term mortality after TURP and for the first time in any large clinical trial, will evaluate the effect of these management strategies on the patient's quality of life. Completion of the study should provide valuable information, now lacking in the urological literature, concerning the treatment of the most common urological disease of the aging male.

Original languageEnglish (US)
Pages (from-to)218-223
Number of pages6
JournalWorld Journal of Urology
Volume8
Issue number4
DOIs
StatePublished - Dec 1990

Fingerprint

Transurethral Resection of Prostate
Prostatic Hyperplasia
Randomized Controlled Trials
Watchful Waiting
Urologic Diseases
Dilatation
Quality of Life
Clinical Trials
Mortality
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

The treatment of benign prostatic hyperplasia : a prospective, randomized clinical trial to be conducted by the American Urological Association. / Holtgrewe, H. Logan.

In: World Journal of Urology, Vol. 8, No. 4, 12.1990, p. 218-223.

Research output: Contribution to journalArticle

@article{90653364bfdd4edfb537efdcc1cb8b9f,
title = "The treatment of benign prostatic hyperplasia: a prospective, randomized clinical trial to be conducted by the American Urological Association",
abstract = "Through a large nationwide, multicenter, prospective, randomized and preferential clinical trial, the American Urological Association plans to evaluate the efficacy of watchful waiting, alpha-blockade, balloon dilation, and transurethral prostatectomy (TURP) in the treatment of benign prostatic hyperplasia. The study, to be conducted at 20 major urological centers in the United States, will primarily address the issue of long-term mortality after TURP and for the first time in any large clinical trial, will evaluate the effect of these management strategies on the patient's quality of life. Completion of the study should provide valuable information, now lacking in the urological literature, concerning the treatment of the most common urological disease of the aging male.",
author = "Holtgrewe, {H. Logan}",
year = "1990",
month = "12",
doi = "10.1007/BF01580024",
language = "English (US)",
volume = "8",
pages = "218--223",
journal = "World Journal of Urology",
issn = "0724-4983",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - The treatment of benign prostatic hyperplasia

T2 - a prospective, randomized clinical trial to be conducted by the American Urological Association

AU - Holtgrewe, H. Logan

PY - 1990/12

Y1 - 1990/12

N2 - Through a large nationwide, multicenter, prospective, randomized and preferential clinical trial, the American Urological Association plans to evaluate the efficacy of watchful waiting, alpha-blockade, balloon dilation, and transurethral prostatectomy (TURP) in the treatment of benign prostatic hyperplasia. The study, to be conducted at 20 major urological centers in the United States, will primarily address the issue of long-term mortality after TURP and for the first time in any large clinical trial, will evaluate the effect of these management strategies on the patient's quality of life. Completion of the study should provide valuable information, now lacking in the urological literature, concerning the treatment of the most common urological disease of the aging male.

AB - Through a large nationwide, multicenter, prospective, randomized and preferential clinical trial, the American Urological Association plans to evaluate the efficacy of watchful waiting, alpha-blockade, balloon dilation, and transurethral prostatectomy (TURP) in the treatment of benign prostatic hyperplasia. The study, to be conducted at 20 major urological centers in the United States, will primarily address the issue of long-term mortality after TURP and for the first time in any large clinical trial, will evaluate the effect of these management strategies on the patient's quality of life. Completion of the study should provide valuable information, now lacking in the urological literature, concerning the treatment of the most common urological disease of the aging male.

UR - http://www.scopus.com/inward/record.url?scp=0025610942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025610942&partnerID=8YFLogxK

U2 - 10.1007/BF01580024

DO - 10.1007/BF01580024

M3 - Article

VL - 8

SP - 218

EP - 223

JO - World Journal of Urology

JF - World Journal of Urology

SN - 0724-4983

IS - 4

ER -